This title will be presented as highly practical information pn pharmaceutical antiplatelet and anticoagulation therapy, written in a quick-access, no-nonsense format. The emphasis will be on a just-the-facts clinical approach, heavy on tabular material, light on dense prose.
The involvement of the ISCP will ensure that the best quality contributors will be involved and establish a consistent approach to each topic in the series.
Each volume is designed to be between 120 and 250 pages containing practical illustrations and designed to improve understand and practical usage of cardiovascular drugs in specific clinical areas.
This title will be presented as highly practical information pn pharmaceutical antiplatelet and anticoagulation therapy, written in a quick-access, no-nonsense format. The emphasis will be on a just-the-facts clinical approach, heavy on tabular material, light on dense prose.
The involvement of the ISCP will ensure that the best quality contributors will be involved and establish a consistent approach to each topic in the series.
Each volume is designed to be between 120 and 250 pages containing practical illustrations and designed to improve understand and practical usage of cardiovascular drugs in specific clinical areas.
Antiplatelet agents: current and novel.- Antiplatelet Drug Resistance and Variability in Response: The Role of Antiplatelet Therapy Monitoring.- Anticoagulant Drugs: Current and Novel.- Primary prevention of cardiovascular disease.- Approaches to the Prophylaxis and Treatment of Venous and Cardiac Thromboembolic Disease.
From the reviews:“This book is designed as an accessible, up-to date reference for clinicians using antiplatelet and anticoagulation therapy. The intended audience is the ‘busy clinician,’ but clearly the book is meant for those with regular exposure to patients with cardiovascular disease, acute coronary syndromes, and thromboembolic disease including emergency physicians, cardiologists, and primary care physicians. … This book coincides with a relative explosion of new therapeutic options of antiplatelets and anticoagulants and is a useful addition to the literature.” (Don Allen Davis, Doody’s Book Reviews, May, 2013)
|
Ask a Question About this Product More... |
|
